News
24 August 2021

In Conversation: Stalled progress in cancer care

Dr Cary Adams, CEO of UICC and Charles Goddard, Editorial Director at the Economist Group, review the progress made in cancer care in the past decade and how to respond to the setbacks due to COVID-19. 

Cancer care has seen numerous encouraging developments in the past decade but has suffered setbacks due to the ongoing pandemic. 

In this conversation, Charles Goddard, Editorial Director at The Economist Group, speaks to Cary Adams, CEO of UICC, discuss how the COVID-19 pandemic has reversed much of the progress made in cancer care around the world, the backlog of screenings and treatment, the long-term consequences for cancer services and the general lack of media coverage of this issue.

importantly, they speak about the potential silver linings arising from the pandemic for cancer care and the need to address cancer not just as a health issue but also an economic one. Together they also

 

Last update

Tuesday 24 August 2021

Share this page

Related content

Man sitting at a desk weighing out medication

The World Bank and WHO recently hosted a high-level international event seeking to address the critical challenge of sustainable financing for NCDs and mental health, which collectively represent a significant burden on global health systems.

Cary Adams, CEO of UICC

Acknowledged for his role in leadership development and contributions to global healthcare through his work at UICC, Cary Adams is set to formally receive the award in a ceremony on 14 November 2023 in Chicago.